President of the Board

Evangelos J. Giamarellos-Bourboulis

He graduated from the National and Kapodistrian University of Athens Medical School in 1994, where he also completed his PhD in 1998 entitled “The in vitro activity of polyunsaturated fatty acids on Gram-negative bacteria”. He finished his training in Internal Medicine in Laikon Athens Hospital in 2001 and he specialized in the immunology of infectious disease at the Radboud University Nijmegen, The Netherlands in 2006-2007. He is currently Professor of Internal Medicine at Athens Medical School and Supervisor of the Immunology of Infectious Diseases Laboratory and Out-Patient Centre at ATTIKON University Hospital. He is the director of  MSc in Infectious Diseases at the National and Kapodistrian School of Medicine in Athens, Greece. His research interests include the pathogenesis of sepsis with emphasis on immunoparalysis, innate immunity and biological therapies in hidradenitis suppurativa, and in vitro activities and pharmacokinetic of antimicrobials and their interactions on multidrug- resistant species. In 2009 he was awarded the Young Investigator Research Award of the European Society of Clinical Microbiology and Infectious Diseases. He is the first who described the complex immune dysregulation of COVID-19. He has published 559 peer-reviewed articles in international scientific journals. He has 38,415 citations with h-index 92. He serves as the current President of the European Sepsis Alliance and he is a board member of the Global Sepsis Alliance. He is also the President of the Hellenic Society for Chemotherapy and the coordinator of the Hellenic Sepsis Study Group.